Journal of International Obstetrics and Gynecology ›› 2021, Vol. 48 ›› Issue (6): 615-619.doi: 10.12280/gjfckx.20210185
• Research on Gynecological Malignancies:Review • Previous Articles Next Articles
ZHAI Jia-wei, XU Fang-yu, LI Li△()
Received:
2021-02-24
Published:
2021-12-15
Online:
2021-12-30
Contact:
LI Li
E-mail:lily_lucky@163.com
ZHAI Jia-wei, XU Fang-yu, LI Li. Research Progress of Double Primary Breast and Ovarian Cancer[J]. Journal of International Obstetrics and Gynecology, 2021, 48(6): 615-619.
Add to citation manager EndNote|Ris|BibTeX
[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. doi: 10.3322/caac.21492.
doi: 10.3322/caac.21492 |
[2] |
DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019[J]. CA Cancer J Clin, 2019,69(6):438-451. doi: 10.3322/caac.21583.
doi: 10.3322/caac.21583 |
[3] |
Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018[J]. CA Cancer J Clin, 2018,68(4):284-296. doi: 10.3322/caac.21456.
doi: 10.3322/caac.21456 |
[4] |
Chen C, Xu Y, Huang X, et al. Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer[J]. Medicine(Baltimore), 2020,99(32):e21560. doi: 10.1097/MD.0000000000021560.
doi: 10.1097/MD.0000000000021560 |
[5] |
Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers[J]. JAMA, 2017,317(23):2402-2416. doi: 10.1001/jama.2017.7112.
doi: 10.1001/jama.2017.7112 pmid: 28632866 |
[6] |
Shao D, Cheng S, Guo F, et al. Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals[J]. Cancer Sci, 2020,111(2):647-657. doi: 10.1111/cas.14242.
doi: 10.1111/cas.14242 |
[7] |
Kwong A, Ho J, Shin VY, et al. Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels[J]. Oncotarget, 2018,9(8):7832-7843. doi: 10.18632/oncotarget.23471.
doi: 10.18632/oncotarget.23471 pmid: 29487695 |
[8] |
Rodríguez-Balada M, Roig B, Melé M, et al. Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients[J]. Clin Biochem, 2020,76:17-23. doi: 10.1016/j.clinbiochem.2019.11.014.
doi: S0009-9120(19)30856-2 pmid: 31786208 |
[9] |
Daly MB, Pilarski R, Yurgelun MB, et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020[J]. J Natl Compr Canc Netw, 2020,18(4):380-391. doi: 10.6004/jnccn.2020.0017.
doi: 10.6004/jnccn.2020.0017 |
[10] |
Renault AL, Mebirouk N, Fuhrmann L, et al. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers[J]. Breast Cancer Res, 2018,20(1):28. doi: 10.1186/s13058-018-0951-9.
doi: 10.1186/s13058-018-0951-9 |
[11] |
Cipriano NM Jr, de Brito AM, de Oliveira ES, et al. Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil[J]. Breast Cancer, 2019,26(3):397-405. doi: 10.1007/s12282-018-00938-z.
doi: 10.1007/s12282-018-00938-z pmid: 30535581 |
[12] |
Li S, Jiang K, Li J, et al. Estrogen enhances the proliferation and migration of ovarian cancer cells by activating transient receptor potential channel C3[J]. J Ovarian Res, 2020,13(1):20. doi: 10.1186/s13048-020-00621-y.
doi: 10.1186/s13048-020-00621-y |
[13] |
Chiu HY, Huang CJ, Fan YC, et al. Insomnia But Not Hypnotics Use Associates with the Risk of Breast Cancer: A Population-Based Matched Cohort Study[J]. J Womens Health(Larchmt), 2018,27(10):1250-1256. doi: 10.1089/jwh.2017.6626.
doi: 10.1089/jwh.2017.6626 |
[14] |
Engel CL, Rasanayagam MS, Gray JM, et al. Work and Breast Cancer: Recommendations to Address Research Needs[J]. New Solut, 2018,28(1):79-95. doi: 10.1177/1048291118758713.
doi: 10.1177/1048291118758713 |
[15] | Indrielle-Kelly T, Frühauf F, Burgetová A, et al. Diagnosis of endometriosis 1st part - Overview of diagnostic approaches[J]. Ceska Gynekol, 2019,84(4):252-259. |
[16] |
Li N, Deng Y, Zhou L, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017[J]. J Hematol Oncol, 2019,12(1):140. doi: 10.1186/s13045-019-0828-0.
doi: 10.1186/s13045-019-0828-0 |
[17] |
Reinert T, Nogueira-Rodrigues A, Kestelman FP, et al. The Challenge of Evaluating Adnexal Masses in Patients With Breast Cancer[J]. Clin Breast Cancer, 2018,18(4):e587-e594. doi: 10.1016/j.clbc.2018.03.006.
doi: 10.1016/j.clbc.2018.03.006 |
[18] |
Bruchim I, Ben-Harim Z, Piura E, et al. Preoperative clinical and radiological features of metastatic ovarian tumors[J]. Arch Gynecol Obstet, 2013,288(3):615-619. doi: 10.1007/s00404-013-2776-1.
doi: 10.1007/s00404-013-2776-1 pmid: 23471547 |
[19] |
Hann LE, Lui DM, Shi W, et al. Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation[J]. Radiology, 2000,216(1):242-247. doi: 10.1148/radiology.216.1.r00jl15242.
doi: 10.1148/radiology.216.1.r00jl15242 pmid: 10887255 |
[20] |
Lamovec J, Bracko M. Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study[J]. J Surg Oncol, 1991,48(1):28-33. doi: 10.1002/jso.2930480106.
doi: 10.1002/jso.2930480106 pmid: 1653879 |
[21] |
Abd El hafez A, Monir A. Diagnostic spectrum of ovarian masses in women with breast cancer; magnetic resonance imaging: histopathology correlation[J]. Ann Diagn Pathol, 2013,17(5):441-447. doi: 10.1016/j.anndiagpath.2013.06.003.
doi: 10.1016/j.anndiagpath.2013.06.003 pmid: 23891503 |
[22] |
Peters IT, van Zwet EW, Smit VT, et al. Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study[J]. PLoS One, 2017,12(1):e0168277. doi: 10.1371/journal.pone.0168277.
doi: 10.1371/journal.pone.0168277 |
[23] |
车利, 任军, 邸立军, 等. GCDFP-15对乳腺癌卵巢转移的诊断价值[J]. 肿瘤防治研究, 2009,36(11):944-949. doi: 10.3971/j.issn.1000-8578.2009.11.012.
doi: 10.3971/j.issn.1000-8578.2009.11.012 |
[24] |
Espinosa I, Gallardo A, D′Angelo E, et al. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases[J]. Int J Gynecol Pathol, 2015,34(3):257-265. doi: 10.1097/PGP.0000000000000155.
doi: 10.1097/PGP.0000000000000155 pmid: 25844549 |
[25] |
李宁, 吴令英, 张蓉, 等. 遗传性乳腺癌卵巢癌91例临床分析[J]. 中华肿瘤杂志, 2005,27(4):245-247. doi: 10.3760/j.issn:0253-3766.2005.04.017.
doi: 10.3760/j.issn:0253-3766.2005.04.017 |
[26] |
Moorman PG, Havrilesky LJ, Gierisch JM, et al. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis[J]. J Clin Oncol, 2013,31(33):4188-4198. doi: 10.1200/JCO.2013.48.9021.
doi: 10.1200/JCO.2013.48.9021 |
[27] |
Kotsopoulos J, Lubinski J, Moller P, et al. Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers[J]. Breast Cancer Res Treat, 2014,143(3):579-586. doi: 10.1007/s10549-013-2823-4.
doi: 10.1007/s10549-013-2823-4 |
[28] |
Marchetti C, De Felice F, Palaia I, et al. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers[J]. BMC Womens Health, 2014,14:150. doi: 10.1186/s12905-014-0150-5.
doi: 10.1186/s12905-014-0150-5 pmid: 25494812 |
[29] |
Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality[J]. JAMA, 2010,304(9):967-975. doi: 10.1001/jama.2010.1237.
doi: 10.1001/jama.2010.1237 pmid: 20810374 |
[30] |
Choi YH, Terry MB, Daly MB, et al. Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants[J]. JAMA Oncol, 2021,7(4):585-592. doi: 10.1001/jamaoncol.2020.7995.
doi: 10.1001/jamaoncol.2020.7995 |
[31] |
Chae S, Kim EK, Jang YR, et al. Effect of risk-reducing salpingo-oophorectomy on quality of life in Korean BRCA mutation carriers[J]. Asian J Surg, 2021,44(8):1056-1062. doi: 10.1016/j.asjsur.2021.01.007.
doi: 10.1016/j.asjsur.2021.01.007 |
[32] |
Becaria Coquet J, Caballero VR, Camisasso MC, et al. Diet Quality, Obesity and Breast Cancer Risk: An Epidemiologic Study in Córdoba, Argentina[J]. Nutr Cancer, 2020,72(6):1026-1035. doi: 10.1080/01635581.2019.1664601.
doi: 10.1080/01635581.2019.1664601 pmid: 31559865 |
[33] |
Khan S, Ayub H, Khan T, et al. MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer[J]. Biochimie, 2019,167:12-24. doi: 10.1016/j.biochi.2019.09.001.
doi: 10.1016/j.biochi.2019.09.001 |
[1] | CHEN Xiao-juan, ZHANG Yan-xin. A Case of Full-Term Delivery in A Pregnant Patient with Hemophilia A [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 158-160. |
[2] | ZHANG Hao-sheng, WEI Fang. Research Progress of Nectin-4 in Gynecologic Malignancies [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 165-168. |
[3] | JIANG Ai-mei, ZHANG Xin-mei. Advances in the Treatment of Abdominal Wall Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 211-216. |
[4] | BAI Yao-jun, WANG Si-yao, LING Fei-fei, ZHANG Sen-huai, LI Hong-li, LIU Chang. Progress of Trop-2 and Targeted Trop-2 Antibody-Coupled Drugs in Gynecological Malignant Tumors [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 1-7. |
[5] | HOU Chun-yan, DU Xiu-ping. Two Cases of Spontaneous Uterine Rupture in the Middle and Late Stages of Pregnancy [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 110-113. |
[6] | ZHONG Pei-qu, ZHAO Li-jian, ZOU Xin-xin. A Case of Rudimentary Horn Pregnancy Undergoing Expectant Treatment until the Third Trimester [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 114-116. |
[7] | ZHANG Yun-feng, ZHANG Wan-yue, LU Yue, WANG Yang-yang, JING Jia-yu, MU Jing-yi, WANG Yue. Research Progress of ARID1A and PIK3CA Mutations in Malignant Transformation of Ovarian Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 19-22. |
[8] | LI Nan, PENG Er-xuan, LIU Feng-hua. Clinical Analysis of 20 Cases of Brain Metastasis from Ovarian Epithelial Carcinoma [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 23-27. |
[9] | PAN Qi, FENG Tong-fu, JIN Jing, WU Ying, DU Xin. Laparoscopic Resection of Giant Mature Retroperitoneal Teratoma in An Adult: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 28-31. |
[10] | JIA Yan-feng, WU Zhen-zhen, WANG Wei-hong, WANG Yue-yuan, LI Juan. A Case of Primary Ovarian Adenosquamous Carcinoma [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 32-36. |
[11] | SONG Li-fang, WU Zhen-zhen, MAO Bao-hong, ZHAO Xiao-li, LIU Qing. A Case of Isolated Lymph Node Metastasis from Ovarian Cancer to the Inguinal Region [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 37-41. |
[12] | SHI Bai-chao, WANG Yu, CHANG Hui, LU Feng-juan, GUAN Mu-xin, YU Jian-nan, WU Xiao-ke. Mechanism of Traditional Chinese Medicine and Natural Products in Improving Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 66-71. |
[13] | LI Heng-bing, YUAN Hai-ning, ZHANG Yun-jie, ZHANG Jiang-lin, GUO Zi-zhen, SUN Zhen-gao. Advances in Exosome-Based Therapy for Chronic Endometritis by Modulating the Immune Microenvironment [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 72-78. |
[14] | ZHANG Ye, CHEN Qiao-yun, ZHAO Jia-yi, CHEN Lu, LIU Jian-rong. Progress in the Application of Nanoparticles in the Prevention and Treatment of Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 8-12. |
[15] | XI Xin-xin, GUO Hong, LI Shan, FENG Di, LIU Duo-duo. Effect of Preoperative Oral Carbohydrate on Enhanced Recovery after Cesarean Section [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 616-619. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||